Switched to Cost Plus Drugs at 7.5 mg PO once daily for Meloxicam; monthly out-of-pocket dropped to $4.50 compared with $19.00 retail.
Meloxicam
Brand Reference: Mobic
Meloxicam Clinical & Real-World Cost Fact Matrix
| Metric | Verified Benchmark | Source |
|---|---|---|
| Meloxicam RxNorm Concept ID | 41493 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0250 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $19.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $4.70 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $5.50 / mo | 31 Zero-PHI Verified Patient Logs |
Verified Online Prescribers & Wholesale Pharmacies for Meloxicam
Meloxicam Clinical Pharmacology & DailyMed Monograph
RxCUI 41493 • NDC 00378-1089-01Preferentially inhibits inducible COX-2 over COX-1 across a full 20-hour plasma half-life, delivering 24-hour once-daily osteoarthritis and tendinopathy anti-inflammatory coverage.
CMS National Average Drug Acquisition Cost (NADAC) tracking places Meloxicam (Mobic, RxCUI 41493) at $0.0250 per unit, whereas walk-in chain pharmacies bill cash patients an average of $19.00 monthly—creating a 75% ($14.30/mo) wholesale arbitrage spread down to $4.70.
Systemic exposure to Meloxicam reflects 89% oral absorption kinetics and hepatic cyp2c9 (major) and minor cyp3a4 oxidation to four inactive metabolites, sustaining receptor engagement across a 15–20 hours half-life window (2–4 hours peak synovial distribution response profile).
Dosing protocols (7.5 mg PO once daily or 15 mg PO once daily max) balance efficacy (85.40% patient satisfaction across 31 logs) against mild epigastric fullness (11% of reports), edema (6% of reports), with strict avoidance in cabg surgery; active peptic ulceration; egfr < 30 ml/min.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- CABG surgery
- Active peptic ulceration
- eGFR < 30 mL/min
Logged Side-Effect Incidence (31 Reports)
Meloxicam Patient Dosage Logs & Out-of-Pocket Cost Ledger
Across 31 verified cash-pay logs, Meloxicam achieves a 85.40% Worth-It rating with out-of-pocket spend averaging $5.50/mo versus $19.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Completed 10 weeks on Meloxicam (15 mg PO once daily max). Zero notable side effects on steady dosing.
Consistent biomarker response on 7.5 mg PO once daily Meloxicam sourced via Local Pharmacy ($5.45/mo cash pay without insurance prior authorization).